Human pluripotent stem cells (hPSCs) are viewed as promising candidates for applications in regenerative medicine and therapy due to their proliferative and pluripotent properties. However, obtaining clinically significant numbers of hPSCs remains a limiting factor and impedes their use in therapeutic applications. Conventionally, hPSCs are cultured on two-dimensional surfaces coated with a suitable substrate, such as Matrigel™. This method, however, requires a large surface area to generate sufficient cell numbers to meet clinical needs and is therefore impractical as a manufacturing platform for cell expansion. In addition, the use of enzymes for cell detachment and small molecule inhibitors to increase plating efficiency may impact future cell behavior when used for routine subculturing. In this study, we describe a protocol to generate and maintain hPSC aggregates in a three-dimensional suspension culture by utilizing thermoresponsive nanobridges. The property of the polymer used in the nanobridges enables passaging and expansion through a temperature change in combination with mechanically applied shear to dissociate aggregates; thus, we eliminate the need of enzymes or small molecules for cell dissociation and viability, respectively. Utilizing this platform, maintenance of human embryonic stem cells for three continuous passages demonstrated high expression levels in key pluripotent markers.
Get full access to this article
View all access options for this article.
References
1.
DaleyG.Q.The promise and perils of stem cell therapeutics. Cell Stem Cell, 10, 740, 2012.
2.
EngleS.J., and PuppalaD.Integrating human pluripotent stem cells into drug development. Cell Stem Cell, 12, 669, 2013.
3.
EdmondsonR., BroglieJ.J., AdcockA.F., and YangL.Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. Assay Drug Dev Technol, 12, 207, 2014.
4.
OhS.K., ChenA.K., MokY., et al.Long-term microcarrier suspension cultures of human embryonic stem cells. Stem Cell Res, 2, 219, 2009.
5.
BadenesS.M., FernandesT.G., RodriguesC.A., DiogoM.M., and CabralJ.M.Microcarrier-based platforms for in vitro expansion and differentiation of human pluripotent stem cells in bioreactor culture systems. J Biotechnol, 234, 71, 2016.
6.
SinghH., MokP., BalakrishnanT., RahmatS.N., and ZweigerdtR.Up-scaling single cell-inoculated suspension culture of human embryonic stem cells. Stem Cell Res, 4, 165, 2010.
7.
SteinerD., KhanerH., CohenM., et al.Derivation, propagation and controlled differentiation of human embryonic stem cells in suspension. Nat Biotechnol, 28, 361, 2010.
8.
DerdaR., LiL., OrnerB.P., LewisR.L., ThomsonJ.A., and KiesslingL.L.Defined substrates for human embryonic stem cell growth identified from surface arrays. ACS Chem Biol, 2, 347, 2007.
9.
HashemiS.M., SoudiS., ShabaniI., NaderiM., and SoleimaniM.The promotion of stemness and pluripotency following feeder-free culture of embryonic stem cells on collagen-grafted 3-dimensional nanofibrous scaffold. Biomaterials, 32, 7363, 2011.
10.
IkedaK., NagataS., OkitsuT., and TakeuchiS.Cell fiber-based three-dimensional culture system for highly efficient expansion of human induced pluripotent stem cells. Scientific Rep, 7, 2850, 2017.
11.
LeiY., and SchafferD.V.A fully defined and scalable 3D culture system for human pluripotent stem cell expansion and differentiation. Proc Natl Acad Sci U S A, 110, E5039, 2013.
12.
ChenV.C., CoutureS.M., YeJ., et al.Scalable GMP compliant suspension culture system for human ES cells. Stem Cell Res, 8, 388, 2012.
13.
AmitM., ChebathJ., MarguletsV., et al.Suspension culture of undifferentiated human embryonic and induced pluripotent stem cells. Stem Cell Rev, 6, 248, 2010.
14.
BuzzardJ.J., GoughN.M., CrookJ.M., and ColmanA.Karyotype of human ES cells during extended culture. Nat Biotechnol, 22, 381, 2004.
15.
MitalipovaM.M., RaoR.R., HoyerD.M., et al.Preserving the genetic integrity of human embryonic stem cells. Nat Biotechnol, 23, 19, 2005.
16.
GonzalezR., GaritaonandiaI., CrainA., et al.Proof of concept studies exploring the safety and functional activity of human parthenogenetic-derived neural stem cells for the treatment of Parkinson's disease. Cell Transplant, 24, 681, 2015.
17.
ChenX., ProwseA.B., JiaZ., et al.Thermoresponsive worms for expansion and release of human embryonic stem cells. Biomacromolecules, 15, 844, 2014.
18.
HayashiY., and FurueM.K.Biological effects of culture substrates on human pluripotent stem cells. Stem Cells Int, 2016, 5380560, 2016.
19.
CrapoP.M., GilbertT.W., and BadylakS.F.An overview of tissue and whole organ decellularization processes. Biomaterials, 32, 3233, 2011.
20.
DesaiN., RambhiaP., and GishtoA.Human embryonic stem cell cultivation: historical perspective and evolution of xeno-free culture systems. Reprod Biol Endocrinol, 13, 9, 2015.
21.
ChenG., GulbransonD.R., HouZ., et al.Chemically defined conditions for human iPSC derivation and culture. Nat Methods, 8, 424, 2011.
22.
WangH., LuoX., and LeightonJ.Extracellular matrix and integrins in embryonic stem cell differentiation. Biochem Insights, 8, 15, 2015.
23.
ProwseA.B., DoranM.R., Cooper-WhiteJ.J., et al.Long term culture of human embryonic stem cells on recombinant vitronectin in ascorbate free media. Biomaterials, 31, 8281, 2010.
24.
MuR., KimB.J., PacoC., Del RosarioY., CourtneyH.S., and DoranK.S.Identification of a group B streptococcal fibronectin binding protein, SfbA, that contributes to invasion of brain endothelium and development of meningitis. Infect Immun, 82, 2276, 2014.
25.
GeorgeP.A., DoranM.R., CrollT.I., MunroT.P., and Cooper-WhiteJ.J.Nanoscale presentation of cell adhesive molecules via block copolymer self-assembly. Biomaterials, 30, 4732, 2009.
26.
ElliottD.A., BraamS.R., KoutsisK., et al.NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes. Nat Methods, 8, 1037, 2011.
27.
KesselS., UrbaniC.N., and MonteiroM.J.Mechanically driven reorganization of thermoresponsive diblock copolymer assemblies in water. Angew Chem Int Ed Engl, 50, 8082, 2011.
28.
MeisnerL.F., and JohnsonJ.A.Protocols for cytogenetic studies of human embryonic stem cells. Methods, 45, 133, 2008.
29.
BustinS.A., BenesV., GarsonJ.A., et al.The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem, 55, 611, 2009.
30.
VandesompeleJ., De PreterK., PattynF., et al.Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol, 3, RESEARCH0034, 2002.
31.
PfafflM.W.A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res, 29, e45, 2001.
32.
KnightE., and PrzyborskiS.Advances in 3D cell culture technologies enabling tissue-like structures to be created in vitro. J Anat, 227, 746, 2015.
33.
ChenK.G., MallonB.S., McKayR.D., and RobeyP.G.Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics. Cell Stem Cell, 14, 13, 2014.
34.
KrawetzR., TaianiJ.T., LiuS., et al.Large-scale expansion of pluripotent human embryonic stem cells in stirred-suspension bioreactors. Tissue Eng Part C Methods, 16, 573, 2010.
35.
OlmerR., HaaseA., MerkertS., et al.Long term expansion of undifferentiated human iPS and ES cells in suspension culture using a defined medium. Stem Cell Res, 5, 51, 2010.
36.
OlmerR., LangeA., SelzerS., et al.Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors. Tissue Eng Part C Methods, 18, 772, 2012.
37.
AmitM., CarpenterM.K., InokumaM.S., et al.Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol, 227, 271, 2000.
38.
ReubinoffB.E., PeraM.F., FongC.Y., TrounsonA., and BongsoA.Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol, 18, 399, 2000.
39.
ThomsonJ.A., Itskovitz-EldorJ., ShapiroS.S., et al.Embryonic stem cell lines derived from human blastocysts. Science, 282, 1145, 1998.
40.
DerdaR., MusahS., OrnerB.P., KlimJ.R., LiL., and KiesslingL.L.High-throughput discovery of synthetic surfaces that support proliferation of pluripotent cells. J Am Chem Soc, 132, 1289, 2010.
41.
RodinS., DomogatskayaA., StromS., et al.Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511. Nat Biotechnol, 28, 611, 2010.
42.
MiyazakiT., FutakiS., HasegawaK., et al.Recombinant human laminin isoforms can support the undifferentiated growth of human embryonic stem cells. Biochem Biophys Res Commun, 375, 27, 2008.
43.
BraamS.R., ZeinstraL., LitjensS., et al.Recombinant vitronectin is a functionally defined substrate that supports human embryonic stem cell self-renewal via alphavbeta5 integrin. Stem Cells, 26, 2257, 2008.
44.
RuoslahtiE.The RGD story: a personal account. Matrix Biol, 22, 459, 2003.
45.
MelkoumianZ., WeberJ.L., WeberD.M., et al.Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human embryonic stem cells. Nat Biotechnol, 28, 606, 2010.
46.
RowlandT.J., MillerL.M., BlaschkeA.J., et al.Roles of integrins in human induced pluripotent stem cell growth on Matrigel and vitronectin. Stem Cells Dev, 19, 1231, 2010.
47.
AmitM., SharikiC., MarguletsV., and Itskovitz-EldorJ.Feeder layer- and serum-free culture of human embryonic stem cells. Biol Reprod, 70, 837, 2004.
48.
LinH., LiQ., and LeiY.An integrated miniature bioprocessing for personalized human induced pluripotent stem cell expansion and differentiation into neural stem cells. Sci Rep, 7, 40191, 2017.
49.
WatanabeK., UenoM., KamiyaD., et al.A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol, 25, 681, 2007.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
